Regional localization of dopamine and ionotropic glutamate receptor subtypes in striatolimbic brain regions

Journal of Neuroscience Research

Volumn 55, Issue 4, 1999, Pages 401-410

  Tarazi, Frank I ^a,b,c   Baldessarini, Ross J ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MCLEAN HOSPITAL   (United States)

Author keywords

Autoradiography; Caudate putamen; Cerebral cortex; Forebrain; Hippocampus; Kainic acid; Nucleus accumbens septi

Indexed keywords

AMPA RECEPTOR; AUTORECEPTOR; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE RECEPTOR; GLUTAMATE RECEPTOR; GLUTAMIC ACID; IONOTROPIC RECEPTOR; KAINIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; OXIDOPAMINE; POSTSYNAPTIC RECEPTOR; PRESYNAPTIC RECEPTOR;

ANIMAL TISSUE; AUTORADIOGRAPHY; BRAIN SURGERY; CAUDATE NUCLEUS; DEAFFERENTATION; DOPAMINERGIC SYSTEM; FOREBRAIN; HIPPOCAMPUS; LIMBIC CORTEX; NERVE CELL DEGENERATION; NEUROTRANSMITTER RELEASE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PUTAMEN; RAT; RECEPTOR BINDING; RECEPTOR DENSITY; REGULATORY MECHANISM; REVIEW; STRIATE CORTEX;

ANIMALS; BINDING SITES; FRONTAL LOBE; HIPPOCAMPUS; KAINIC ACID; LIMBIC SYSTEM; NEOSTRIATUM; NERVE DEGENERATION; NUCLEUS ACCUMBENS; PROSENCEPHALON; RATS; RECEPTORS, DOPAMINE; RECEPTORS, GLUTAMATE; VISUAL CORTEX;

EID: 0033558316     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19990215)55:4<401::AID-JNR1>3.0.CO;2-H     Document Type: Review

References (79)

1. Albin RL, Makowiec RL, Hollingsworth ZR, Dure IV LS, Penney JB, Young AB. 1992. Excitatory amino acid binding sites in the basal ganglia of the rat: a quantitative autoradiographic study. Neuroscience 46:35-48.
2. 3 subtypes. Brain Res 649:95-110.
3. 2 dopamine receptor distribution in the rodent CNS using anti-peptide antisera. Brain Res 609:71-80.
4. Ariano MA, Larson ER, Noblett KL, Sibley DR, Levine MS. 1997. Coexpression of striatal dopamine receptor subtypes and excitatory amino acid subunits. Synapse 26:400-414.
5. Baldessarini RJ. 1996. Drugs and the treatment of psychiatric disorders. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG, editors. Goodman and Gilman's the pharmacologic basis of therapeutics. New York: McGraw-Hill. p 399-459.
6. Baldessarini. 1997. Dopamine receptors and clinical medicine. In: Neve KA, Neve RL. editors. The dopamine receptors. Totowa, NJ: Humana Press, p 457-498.
7. Baldessarini RJ, Tarazi FI. 1996. Brain dopamine receptors: a primer on their current status, basic and clinical. Harvard Rev Psychiatry 3:301-325.
8. Baldessarini RJ, Tarsy D. 1979. Relationship of the actions of neuroleptic drugs to the pathophysiology of tardive dyskinesia. Int Rev Neurobiol 21:1-45.
9. Barbeito L, Cheramy A, Godeheu G, Desce JM, Glowinski J. 1990. Glutamate receptors of a quisqualate-kainate subtype are involved in the presynaptic regulation of dopamine release in the cat caudate nucleus in vivo. Eur J Neurosci 2:304-311.
10. Benes FM. 1995. Is there a neuroanatomic basis for schizophrenia? An old question revisited. Neuroscientist 1:104-115.
11. Bernard V, Somogyi P, Bolam JP. 1997. Cellular, subcellular, and subsynaptic distribution of AMPA-type glutamate receptor subunits in the neostriatum of the rat. J Neurosci 17:819-833.
12. Biziere K, Coyle JT 1979. Effects of cortical ablation on the neurotoxicity and receptor binding of kainic acid in striatum. J Neurosci Res 4:383-398.
13. 3H]L-glutamic acid in rat brain membranes. Brain Res 183:421-433.
14. Booth RG, Baldessarini RJ, Kula NS, Gao Y, Zong R. Neumeyer JL. 1990. Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines. Mol Pharmacol 38:92-101.
15. Booth RG, Baldessarini RJ, Campbell A. 1991. Inhibition of dopamine synthesis in rat striatal minces: evidence of dopamine autoreceptor supersensitivity to S(+) but not R(-) N-n-propylnor-apomorphine after pretreatment with fluphenazine. Biochem Pharmacol 41:2040-2043.
16. Calabresi P, Mercuri NB, Bmardi G. 1993. Chemical modulation of synaptic transmission in the striatum. Prog Brain Res 99:299-308.
17. 2 receptors in the brain of several mammlian species. J Neural Transm 80:105-127.
18. Carlsson M, Carlsson A. 1990. Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease. Trends Neurosci 13:272-276.
19. Cepeda C, Levine MS. 1998. Dopamine and N-methyl-D-aspartate receptor interactions in the neostriatum. Dev Neurosci 20:1-18.
20. Christoffersen CL, Meltzer LT. 1995. Evidence for N-methyl-D-aspartate and AMPA subtypes of the glutamate receptor on substantia nigra dopamine neurons: possible preferential role for N-methyl-D-aspartate receptors. Neuroscience 67:373-381.
21. Davis KL, Kahn RS, Ko G, Davidson M. 1991. Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry 148:1474-1486.
22. 4 dopamine receptor in rat brain with sequence-specific antibodies. Mol Brain Res 45:1-12.
23. Di Chiara G, Morelli M, Consolo S. 1994. Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions. Trends Neurosci 17:228-233.
24. 3H]glutamic acid binding to rat striatal membranes: effects of selective striatal lesions and deafferentations. Brain Res 366:178-186.
25. 3H] Amino-3-hydroxy-5-methyl-4-isoazolepropionic acid binding to oral striatal membranes: effects of selective brain lesions. J Neurochem 51:579-586.
26. 3H]sulpiride. Eur J Pharmacol 138:61-68.
27. Flores-Hernandez J, Galarraga E, Bargas J. 1997. Dopamine selects glutamatergic inputs to neostriatal neurons. Synapse 25:185-195.
28. Florijn WJ, Tarazi FI, Creese I. 1997. Dopamine receptor subtypes: Differential regulation following 8 months treatment with antipsychotic drugs. J Pharmacol Exp Ther 280:561 -569.
29. Garcia-Munoz M, Young SJ, Groves PM. 1991. Terminal excitability of the corticostriatal pathway: regulation by dopamine receptor stimulation. Brain Res 551:195-206.
30. Gerfen CR. 1992. The neostriatal mosaic: multiple levels of compartniental organization. Trends Neurosci 15:133-139.
31. Goldnian-Rakic PS, Selemon LD. 1997. Functional and anatomical aspects of prefrontal pathology in schizophrenia. Schizophrenia Bull 23:437-458.
32. Grace AA. 1993. Cortical regulation of subcortical dopamine systems and its possible relevance to schizophrenia. J Neural Transm 91:111-134.
33. Gracy KN, Pickel VM. 1996. Ultrastructural immunocytochemical localization of the N-methyl-D-aspartate receptor and tyrosine hydroxylase in the shell of the rat nucleus accumbens. Brain Res 739:169-181.
34. Greenamyre JT, Young AB. 1989. Synaptic localization of striatal NMDA. quisqualate and kainate receptors. Neurosci Lett 101: 133-137.
35. Greenamyre JT, Olsen JMM, Penney JB, Young AB. 1985. Autoradiographic characterization of N-methyl-D-aspartate-, quisqualate-and kainate-sensitive glutamate binding sites. J Pharmacol Exp Ther 233:254-263.
36. Jeste DV, Lohr JB. 1989. Hippocampal pathologic findings in schizophrenia, a morphometric study. Arch Gen Psychiatry 46:1019-1024.
37. Jones EG. 1984. Laminar distribution of cortical efferent cells. In: Peters A, Jones EG, editors. Cerebral cortex, vol. 1, cellular components of the cerebral cortex. New York: Plenum Press. p 521-553.
38. 2 sites in rat caudate-putamen: localization to intrinsic neurons and not neocortical afferents. Neuroscience 20:773-795.
39. Kebabian JW, Tarazi FI, Kula NS, Baldessarini RJ. 1997. Compounds selective for dopamine receptor subtypes. Drug Discovery Today 2:333-340.
40. Kelley AE, Domesick VB. 1982. The distribution of the projection from the hippocampal formation to the nucleus accumbens in the rat: an anterograde-and retrograde-horseradish peroxidase study. Neuroscience 7:2321-2335.
41. Kerwin R, Patel S, Meldrum B. 1990. Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain postmortem. Neuroscience 39:25-32.
42. Krebs MO, Desce JM, Kemel ML, Gauchy C, Godeheu G, Cheramy A, Glowinski J. 1991. Glutamatergic control of dopamine release in the rat striatum: evidence for presynaptic N-methyl-D-aspartate receptors on dopaminergic nerve terminals. J Neurochem 56:81-85.
43. 2 mRNAs in distinct neuronal populations of the dorsal and ventral striatum. J Comp Neurol 355:418-426.
44. McLennan H. 1980. The effect of decortication on the excitatory amino acid sensitivity of striatal neurons. Neurosci Lett 18:313-316.
45. Monaghan DT, Bridges RJ, Cotwan CW. 1989. The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu Rev Pharmacol Toxicol 29:365-402.
46. Murrin LC, Gale K, Kuhar MJ. 1979. Autoradiographic localization of neuroleptic and dopamine receptors in caudate-putamen and substantia nigra: effects of lesions. Eur J Pharmacol 60:229-235.
47. Neve KA, Neve RL. 1997. The dopamine receptors. Totowa, NJ: Humana Press.
48. Pakkenberg B. 1990. Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. Arch Gen Psychiatry 47:1023-1028.
49. Petralia RS, Wang Y-X, Wenthold RJ. 1994. Histological and ultrastructural localization of the kainate receptor subunits, KA2 and GluR6/7, in the rat nervous system using selective antipeptide antibodies. J Comp Neurol 349:85-110.
50. Roberts PJ, McBean GJ, Sharif NA, Thomas EM. 1982. Striatal glutamatergic function: Modifications following specific lesions. Brain Res 235:83-91.
51. 3H]3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid binding. J Neurochem 54:1926-1933.
52. Schwarcz R, Creese I, Coyle JT, Snyder SH. 1978. Dopamine receptors localized on cerebral cortical afferents to rat corpus striatum. Nature 271:766-768.
53. Smith AD, Bolam JP. 1990. The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurons. Trends Neurosci 13:259-265.
54. Surmeier DJ, Eberwine J, Wilson CJ, Cao Y, Stefani A, Kitai ST. 1992. Dopamine receptor subtypes co-localize in rat striatonigral neurons. Proc Natl Acad Sci USA 89:10178-10182.
55. Surmeier DJ, Reiner A, Levine MS, Ariano MA. 1993. Are neostriatal dopamine receptors co-localized? Trends Neurosci 16:299-305.
56. Tallaksen-Greene SJ, Wiley RG, Albin RL. 1992. Localization of striatal excitatory amino acid binding site subtypes to striatonigral projection neurons. Brain Res 594:165-170.
57. Tamminga CA. 1998. Schizophrenia and glutamatergic transmission. Crit Rev Neurobiol 12:21-36.
58. Tanabe Y, Masu M, Ishii T, Shigemoto R, Nakanishi S. 1992. A family of metabotropic glutamate receptors. Neuron 8:169-179.
59. Tarazi FI, Florijn WJ, Creese I. 1996. Regulation of ionotropic glutamate receptors following subchronic and chronic treatment with typical and atypical antipsychotics. Psychopharmacology 128:371-379.
60. Tarazi FI, Florijn WJ, Creese I. 1997a. Differential regulation of dopamine receptors following chronic typical and atypical antipsychotic drug treatment. Neuroscience 78:985-996.
61. 4 receptors in rat forebrain. NeuroReport 8:3423-3426.
62. 4-like dopamine receptors. Neuropsychopharmacology 17:186-196.
63. 4-like receptors. Neuroscience 87:1-4.
64. Tarazi FI, Campbell A, Baldessarini RJ. 1998b. Effects of hippocampal kainic acid lesion on striatolimbic ionotropic glutamate NMDA, AMPA and KA receptors. Neurosci Lett 250:13-16.
65. 4-like receptors. Neuroscience 83:169-176.
66. Tarazi FI, Campbell A, Yeghiayan SK, Baldessarini RJ. 1998d. Localization of glutamate receptor subtypes in caudate-putamen and nucleus accumbens septi: Comparison of NMDA, AMPA and kainate receptors. Synapse 30:227-235.
67. 4-like dopamine receptors: common targets for typical, atypical and experimental antipsychotics. Prog Neuro-Psychopharmacol Biol Psychiatry 22:693-707.
68. 3 autoreceptors on nigrostriatal neurons analyzed by antisense knockdown in vivo. J Neurosci 17:2519-2530.
69. 2 receptors exist post-synaptically on corticostriatal afferents and striatal neurons. J Pharm Pharmacol 33:439-444.
70. 2 dopamine receptors on intrinsic striatal neurons by quantitative autoradiography. Nature 323:267-269.
71. Ulas J, Cotman CW. 1993. Excitatory amino acid receptors in schizophrenia. Schizophrenia Bull 19:105-117.
72. Ulas J, Nguyen L, Cotman CW. 1993. Chronic haloperidol treatment enhances binding to NMDA receptors in rat cortex. NeuroReport 4:1049-1051.
73. Wang T, French ED. 1993. Electrophysiological evidence for the existence of NMDA and non-NMDA receptors on rat ventral tegmental dopamine neurons. Synapse 13:270-277.
74. Wolf ME, Roth RH. 1990. Autoreceptor regulation of dopamine synthesis. Ann NY Acad Sci 604:323-343.
75. Wullner U, Standaert DG, Testa CM, Landwehrmeyer GB, Catania MV, Penney JB, Young AB. 1994a. Glutamate receptor expression in rat striatum: effects of deafferentation. Brain Res 647:209-219.
76. Wullner U, Testa CM, Catania MV, Young AB, Penney JB. 1994b. Glutamate receptors in striatum and substantia nigra: effects of medial forebrain bundle lesions. Brain Res 645:98-102.
77. Yamamoto BK, Davy S. 1992. Dopaminergic modulation of glutamate release in striatum as measured by microdialysis. J Neurochem 58:1736-1742.
78. Young AB, Fagg GE. 1990. Excitatory amino acid receptors in the brain: membrane binding and receptor autoradiographic approaches. Trends Pharmacol Sci 11:126-133.
79. 3H]kainate binding in rat caudate-putamen and nucleus accumbens after 6-hydroxydopamine lesions of the medial forebrain bundle: An autoradiographic study. Brain Res 731:132-140.